Optimi Health (OPTI) Registration filing summary

Management team and governance

• CEO, Chief Marketing Officer, and Director roles are held by Dane Stevens, who signed the filing in Vancouver, BC on April 21, 2026.

• Interim Chief Financial Officer and Director is Jacob Safarik; Chief Operating Officer and Director is Bryan Safarik.

• Chairman and Director is John James Wilson; Jason Mosberian is also listed as Director.

• U.S. authorized representative is Colleen A. De Vries, Sr. Vice President at Cogency Global Inc., who signed in New York.

Offering details and pricing

• Registration statement filed as Amendment No. 6 to Form F-1, with the offering to commence as soon as practicable after effectiveness.

• Securities may be offered on a delayed or continuous basis under Rule 415.

• Filing Fee Table included as Exhibit 107 in this amendment.

Underwriters and syndicate

• Form of Underwriting Agreement and Form of Underwriter Warrant are included as exhibits.

• Opinions regarding validity and enforceability of shares and warrants provided by Norton Rose Fulbright Canada LLP and US LLP.